When Buying Car Insurance, Young Drivers Should Stick with Mom and Dad
The parents of young drivers have enough to worry about, but a new study from insuranceQuotes.com finds that those who add coverage for an 18-to-24-year-old can expect to see an average annual premium increase of 80 percent on their existing car insurance. The good news: That’s still cheaper than if the young drivers bought insurance on their own. If those young drivers were to buy individual plans of their own, they’d pay 8 percent more on average — and in some cases, over 50 percent more — than their coverage costs on a parental plan.
Related: The Shocking Secret About How Your Car Insurance Rate Gets Set
Premiums can vary widely depending on the driver’s age and state. An 18-year-old can expect to pay an average of 18 percent more for an individual policy than he or she would if added to an existing policy. But in Rhode Island, an 18-year-old will pay an average of 53 percent more for an individual policy. In Connecticut and Oregon, the difference is 47 percent.
In states such as Arizona, Hawaii, and Illinois, it actually becomes cheaper, on average, for a young driver to get his or her own policy after turning 19. When it comes to determining premiums, Hawaii is the only state that doesn’t allow insurance providers to consider age, gender, or length of driving experience.
These are the five states with the greatest difference in premiums for young drivers buying their own coverage.
1. Rhode Island: 19 percent
2. Connecticut: 16 percent
3. North Carolina: 14 percent
4. Vermont: 14 percent
5. Maine: 14 percent
Related: Now 16-Year-Olds Can Double Your Car Insurance
And these five states have the smallest difference:
1. Hawaii: No difference
2. Illinois: No difference
3. Arizona: 2 percent
4. Mississippi: 5 percent
5. South Carolina: 5 percent.
Top Reads from The Fiscal Times:
- As Politicians Bicker Over Funding, Military Families Cut Back on Vacations
- Why We’re Wasting Billions on Teacher Development
- The Future of War Belongs to the Bots
Tax Refunds Rebound
Smaller refunds in the first few weeks of the current tax season were shaping up to be a political problem for Republicans, but new data from the IRS shows that the value of refund checks has snapped back and is now running 1.3 percent higher than last year. The average refund through February 23 last year was $3,103, while the average refund through February 22 of 2019 was $3,143 – a difference of $40. The chart below from J.P. Morgan shows how refunds performed over the last 3 years.
Number of the Day: $22 Trillion
The total national debt surpassed $22 trillion on Monday. Total public debt outstanding reached $22,012,840,891,685.32, to be exact. That figure is up by more than $1.3 trillion over the past 12 months and by more than $2 trillion since President Trump took office.
Chart of the Week: The Soaring Cost of Insulin
The cost of insulin used to treat Type 1 diabetes nearly doubled between 2012 and 2016, according to an analysis released this week by the Health Care Cost Institute. Researchers found that the average point-of-sale price increased “from $7.80 a day in 2012 to $15 a day in 2016 for someone using an average amount of insulin (60 units per day).” Annual spending per person on insulin rose from $2,864 to $5,705 over the five-year period. And by 2016, insulin costs accounted for nearly a third of all heath care spending for those with Type 1 diabetes (see the chart below), which rose from $12,467 in 2012 to $18,494.
Chart of the Day: Shutdown Hits Like a Hurricane
The partial government shutdown has hit the economy like a hurricane – and not just metaphorically. Analysts at the Committee for a Responsible Federal Budget said Tuesday that the shutdown has now cost the economy about $26 billion, close to the average cost of $27 billion per hurricane calculated by the Congressional Budget Office for storms striking the U.S. between 2000 and 2015. From an economic point of view, it’s basically “a self-imposed natural disaster,” CRFB said.
Chart of the Week: Lowering Medicare Drug Prices
The U.S. could save billions of dollars a year if Medicare were empowered to negotiate drug prices directly with pharmaceutical companies, according to a paper published by JAMA Internal Medicine earlier this week. Researchers compared the prices of the top 50 oral drugs in Medicare Part D to the prices for the same drugs at the Department of Veterans Affairs, which negotiates its own prices and uses a national formulary. They found that Medicare’s total spending was much higher than it would have been with VA pricing.
In 2016, for example, Medicare Part D spent $32.5 billion on the top 50 drugs but would have spent $18 billion if VA prices were in effect – or roughly 45 percent less. And the savings would likely be larger still, Axios’s Bob Herman said, since the study did not consider high-cost injectable drugs such as insulin.
